Patents Assigned to Circe Biomedical, Inc.
  • Patent number: 6300054
    Abstract: The invention relates to a container having astrocytes for use in removing toxins from a biological fluid. The container includes a first port for receiving the biological fluid and a second port through which the biological fluid exits the container. The invention also relates to a method of treating a biological fluid by contacting it with astrocytes.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: October 9, 2001
    Assignee: Circe Biomedical, Inc.
    Inventors: Linda Custer, Claudy Mullon, Roger Butterworth
  • Patent number: 6172180
    Abstract: The present invention relates to a block copolymer containing 1-50 first polymer segments and 1-50 second polymer segments. Each first polymer segment has an average mole fraction of monomers possessing a branch point of 0.0001 to 1, whereas each second polymer segment has an average mole fraction of monomers possessing a branch point of 0 to 0.5. The average molecular weights range from 5-2,000 kDa for the first polymer segments, which constitute 5-95% by weight of the block copolymer. The average molecular weights also range from 5-2,000 kDa for the second polymer segments, which constitute 5-95% by weight of the block copolymer. The ratio of the average mole fraction of monomers possessing a branch point of the second polymer segments to that of the first polymer segments is 0 to 0.5. An example of such a copolymer has ethylene oxide or ethylene oxide/propylene oxide as the first polymer segment and polysulfone as the second polymer segment. This block copolymer can further be blended with a bulk polymer.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: January 9, 2001
    Assignee: Circe Biomedical, Inc.
    Inventors: Lawrence F. Hancock, Stephen M. Fagan, Claudy J.-P. Mullon
  • Patent number: 6136525
    Abstract: An artificial liver support system is described herein which comprises cryopreserved hepatocytes having an initial viability of 80-99%. Further disclosed are hepatocytes cryopreserved by dispensing hepatocytes into freezing containers, freezing the containers from between minus 50 to minus 90 degrees Celsius, storing the containers in liquid or vapor nitrogen, thawing the cryopreserved hepatocytes when ready for use and removing residual cryoprotectant media.
    Type: Grant
    Filed: August 2, 1999
    Date of Patent: October 24, 2000
    Assignee: Circe Biomedical, Inc.
    Inventors: Claudy Jean-Paul Mullon, Shawn Paul Cain, Timothy Jon Perlman, Hugo O. Jauregui, Sharda Naik, Henry A. Santangini, Donna M. Trenkler
  • Patent number: 6136593
    Abstract: The invention relates to a container having astrocytes for use in removing toxins from a biological fluid. The container includes a first port for receiving the biological fluid and a second port through which the biological fluid exits the container. The invention also relates to a method of treating a biological fluid by contacting it with astrocytes.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: October 24, 2000
    Assignee: Circe Biomedical, Inc.
    Inventors: Linda Custer, Claudy Mullon, Roger Butterworth
  • Patent number: 6068775
    Abstract: The invention relates to a method of removing an agent from a suspension of cells using a semi-permeable membrane. In one aspect of the invention, the cells are used to bioprocess a biological fluid after removal of the agent.
    Type: Grant
    Filed: April 13, 1998
    Date of Patent: May 30, 2000
    Assignee: Circe Biomedical, Inc.
    Inventors: Linda M. Custer, Shawn P. Cain, Barbara A. Chandler
  • Patent number: 6042909
    Abstract: The invention features an empty device for receiving a bioactive agent. The device includes a biocompatible and semi-permeable membrane that defines an enclosed space; the membrane also has at least one end that defines an opening for introducing the bioactive agent into the enclosed space. The device is configured to be placed in an animal.In one embodiment of the invention, the membrane has an inner surface and an outer surface, where the inner surface defines the inner surface, and includes a biocompatible adhesive in the general region of the opening to allow sealing of the opening after the introduction of the bioactive agent into the enclosed space.Another embodiment of the invention includes a biocompatible frame mounted in supporting relationship to the membrane and defining an opening for introducing the bioactive agent into the enclosed space. The frame has greater porosity than the membrane.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: March 28, 2000
    Assignee: Circe Biomedical, Inc.
    Inventors: Karen E. Dunleavy, Timothy J. Perlman, Kerry A. Gagnon, Claudy J. P. Mullon
  • Patent number: 6023009
    Abstract: An artificial pancreas is described herein which comprises one or more viable and physiologically active pancreatic islet cells capable of producing insulin, encapsulated within a semipermeable spheroidal membrane comprising agar gel. Further disclosed are a method for producing agar microbeads, a tissue implantation method and a reseeding method for the artificial pancreas.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: February 8, 2000
    Assignee: Circe Biomedical, Inc.
    Inventors: Jan Philip Stegemann, John Joseph O'Neil, Claudy Jean Paul Mullon
  • Patent number: 5912163
    Abstract: The invention is based in part on the observation that significant portions of porcine livers appear to remain intact after perfusion by standard methods, suggesting that the perfusion procedures employed do not result in complete enzymatic digestion. Recovery of cells is therefore substantially lower than would be possible if the organs were thoroughly digested. It is found that increased perfusion flow rate, occlusion of at least one major blood vessel leading out of the organ, increased enzymatic digestion time, and vigorous tissue dissociation techniques can be combined to afford a uniquely high yield of viable cells.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: June 15, 1999
    Assignee: Circe Biomedical, Inc.
    Inventors: Kermit M. Borland, Barbara A. Chandler, Dianna Hunt Picton, Shawn P. Cain, Deborah Deane, Claudy J.P. Mullon
  • Patent number: 5834583
    Abstract: A poly(ethyleneoxy) block copolymer including a hydrophobic block segment useful in making a porous polymer article with improved surface hydrophilicity. Also disclosed is a method of making such a polymer article.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: November 10, 1998
    Assignee: Circe Biomedical, Inc.
    Inventors: Lawrence Francis Hancock, Alan Jay Kishbaugh, Marc Ellous Parham
  • Patent number: 5798437
    Abstract: An amphiphilic block copolymer including a hydrophilic internal segment and polymeric articles made therefrom.
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: August 25, 1998
    Assignee: Circe Biomedical, Inc.
    Inventors: Lawrence Francis Hancock, Alan Jay Kishbaugh, Marc Ellous Parham
  • Patent number: 5795711
    Abstract: An artificial liver support system is described herein which comprises cryopreserved hepatocytes having an initial viability of 80-99% and a metabolic activity 50-80% of fresh hepatocytes. Further disclosed are hepatocytes cryopreserved by dispensing hepatocytes into freezing containers, freezing the containers from between minus 50 to minus 90 degrees Celsius, storing the containers in liquid or vapor nitrogen, thawing the cryopreserved hepatocytes when ready for use and removing residual cryoprotectant media.
    Type: Grant
    Filed: April 4, 1996
    Date of Patent: August 18, 1998
    Assignee: Circe Biomedical, Inc.
    Inventors: Claudy Jean-Paul Mullon, Shawn Paul Cain, Timothy Jon Perlman, Hugo O. Jauregui, Sharda Naik, Henry A. Santangini, Donna M. Trenkler
  • Patent number: 5741334
    Abstract: An artifical pancreatic perfusion device comprising a hollow fiber having a porosity ranging from about 25 Kd to about 200 Kd. The hollow fiber has one end connected to a blood vessel for receiving blood and a second end connected to a blood vessel for returning said blood. Islets of Langerhans surround the hollow fiber. The hollow fiber and islets are surrounded by a housing comprising a semipermeable membrane having a pore size small enough to offer protection to the islets and host from immune reactive substances. Further disclosed is a method for providing and regulating insulin to insulin deficient individuals.
    Type: Grant
    Filed: October 16, 1996
    Date of Patent: April 21, 1998
    Assignee: Circe Biomedical, Inc.
    Inventors: Claudy Jean Paul Mullon, Karen E. Dunleavy
  • Patent number: 5700902
    Abstract: A poly(ethyleneoxy) block copolymer including a hydrophobic block segment useful in making a porous polymer article with improved surface hydrophilicity. Also disclosed is a method of making such a polymer article.
    Type: Grant
    Filed: July 27, 1995
    Date of Patent: December 23, 1997
    Assignee: Circe Biomedical, Inc.
    Inventors: Lawrence Francis Hancock, Alan Jay Kishbaugh, Marc Ellous Parham
  • Patent number: 5700903
    Abstract: A poly(ethyleneoxy) block copolymer including a hydrophobic block segment useful in making a porous polymer article with improved surface hydrophilicity. Also disclosed is a method of making such a polymer article.
    Type: Grant
    Filed: April 18, 1996
    Date of Patent: December 23, 1997
    Assignee: Circe Biomedical, Inc.
    Inventors: Lawrence Francis Hancock, Alan Jay Kishbaugh, Marc Ellous Parham